Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
about
Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investmentEconomic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal studyDrug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectorsEnvironmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992-2002Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facilityA needle in the haystack--the dire straits of needle exchange in Hungary.NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.Geographic approaches to quantifying the risk environment: drug-related law enforcement and access to syringe exchange programmes.Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?Income inequality, drug-related arrests, and the health of people who inject drugs: Reflections on seventeen years of researchHIV and the criminalisation of drug use among people who inject drugs: a systematic review.Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007.
P2860
Q27318250-08E14324-9E96-44E5-9632-70BBB91A2807Q28535029-466DD5F9-7961-4965-BE09-A55369E94E47Q28732206-AEC5D6B1-CB2C-48ED-9DB5-46A0085EB004Q33625208-6BB7C0B2-90BF-4D65-828C-C681F0A4752FQ33717043-90A44CE0-A6F1-4DD2-8879-4BCA0C46BB42Q35924703-DE25566D-FABF-44A3-B21F-4AF07A154E18Q35990579-982E00C9-9296-4E8A-9E48-6BC3346FD7F7Q37069196-0AE68ADD-BE5D-4B08-AD15-17F1C67D5F9EQ37419886-4275ED90-35D5-47A5-B0B1-7840D18F1EC7Q37638230-5A5218F4-AFD8-4E2C-ADA2-38D64C554029Q37691641-00A73E7F-DF4D-4CFB-9311-D5B97BD33DABQ38780301-C1BBA6F7-32EA-4512-8E3B-39712C2BDCF8Q52294502-D11BD5AE-680A-4DFE-998A-ECB8BBEDADE2Q54699126-6A838F8E-A0E4-4D37-8EB2-2B33220802C8
P2860
Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Correlates of syringe coverage ...... is the dominant injected drug.
@en
Correlates of syringe coverage ...... is the dominant injected drug.
@nl
type
label
Correlates of syringe coverage ...... is the dominant injected drug.
@en
Correlates of syringe coverage ...... is the dominant injected drug.
@nl
prefLabel
Correlates of syringe coverage ...... is the dominant injected drug.
@en
Correlates of syringe coverage ...... is the dominant injected drug.
@nl
P2093
P2860
P1476
Correlates of syringe coverage ...... is the dominant injected drug
@en
P2093
Don C Des Jarlais
Hannah L Cooper
Joanne Brady
Karla Gostnell
P2860
P304
P356
10.1016/J.DRUGPO.2007.11.011
P478
19 Suppl 1
P577
2008-03-04T00:00:00Z